Neurons can release damaged mitochondria and transfer them to astrocytes for disposal and recycling 1 . This ability to exchange mitochondria may represent a potential mode of cell-to-cell signalling in the central nervous system. Here we show that astrocytes in mice can also release functional mitochondria that enter neurons. Astrocytic release of extracellular mitochondrial particles was mediated by a calcium-dependent mechanism involving CD38 and cyclic ADP ribose signalling. Transient focal cerebral ischaemia in mice induced entry of astrocytic mitochondria into adjacent neurons, and this entry amplified cell survival signals. Suppression of CD38 signalling by short interfering RNA reduced extracellular mitochondria transfer and worsened neurological outcomes. These findings suggest a new mitochondrial mechanism of neuroglial crosstalk that may contribute to endogenous neuroprotective and neurorecovery mechanisms after stroke.
and may have a role in neuroglial crosstalk since astrocytes increase CD38 expression in response to glutamate release from neurons 16 . On the basis of this background literature and the fact that most actively secreted cellular events involve calcium regulation, we decided to assess CD38-cADPR-calcium signalling as a candidate mechanism for the astrocytic production of extracellular mitochondria. First, we confirmed that rat cortical astrocytes expressed CD38 protein and contained CD38 or ADPR cyclase activity ( Fig. 1f, g) . We then used two methods to modify this pathway. When astrocytic CD38 was upregulated using CRISPR/Cas9 activation plasmids, the functional endpoints of extracellular mitochondria were significantly increased in conditioned media ( Fig. 1h-k) . When astrocytes were stimulated by cADPR to activate CD38 signalling, extracellular mitochondria were increased in conditioned media along with enhancement of functional endpoints in a calcium-dependent manner ( Fig. 1l -n, Extended Data Fig. 3 ). Stimulation with cADPR did not appear to damage astrocyte viability ( Fig. 1o ), suggesting that this release of extracellular mitochondria was not due to nonspecific cytotoxicity.
If astrocytes can produce functional extracellular mitochondria, it is possible that these signals could affect adjacent neurons. When rat cortical neurons were subjected to oxygen-glucose deprivation, intracellular ATP levels fell and neuronal viability decreased, as expected ( Fig. 2a -c, Extended Data Fig. 4a ). When astrocyte-derived conditioned media containing extracellular mitochondrial particles was added to neurons, ATP levels increased and neuronal viability recovered ( Fig. 2a -c, Extended Data Fig. 4a ). However, when extracellular mitochondria were removed from the astrocyte-conditioned media, neuroprotection was no longer observed ( Fig. 2a -c, Extended Data Fig. 4a ). Similar results were obtained with immunostaining-based cell counts ( Fig. 2d ). As a control, ATP-liposomes were not significantly protective ( Fig. 2e ), suggesting that the entry of astrocytic mitochondria into neurons may generate additional benefits beyond ATP energetics per se. Fluorescent microscopy confirmed that astrocyte-derived mitochondria were present within treated neurons ( Fig. 2f and Extended Data Fig. 4b ).
Beyond the prevention of acute neuronal death, delayed neuroplasticity is also important for stroke outcomes. CD38 may be important for brain plasticity because CD38-deficient mice show worsened recovery after brain injury 17 and CD38 mutations may comprise risk factors for behavioural dysfunction 18 . Hence, we asked whether CD38-mediated astrocyte-to-neuron mitochondrial transfer may also influence neuroplasticity. Neurons were labelled with the green fluorescent protein (GFP)-containing construct CellLight Mitochondria-GFP and astrocytes were separately labelled with the red fluorescent probe MitoTracker Red CMXRos, and the two cell types were co-cultured together for 24 h. Confocal microscopy indicated that astrocyte-derived mitochondria were detected within soma and axon (Fig. 3a) , and in these co-culture conditions, astrocytes supported neuronal survival after serum/glucose starvation in a CD38-dependent manner (Extended Data Fig. 5 ). When astrocytic mitochondria to test neuroprotective effects of ACM or mdACM against oxygen-glucose deprivation (OGD) in rat cortical neurons. WST, water-soluble tetrazolium salt dye for cell viability assay. b, ACM but not mdACM rescued ATP levels in damaged neurons (n = 2 biological replicates, n = 4 independent experiments). c, ACM but not mdACM recovered neuronal viability after OGD (n = 2 biological replicates, n = 4 independent experiments). d, Immunostaining confirmed that neuroprotective effect of ACM but not mdACM (n = 2 biological replicates, n = 4 independent experiments). NeuN , and oxygen consumption (e, n = 3 biological replicates, n = 9 or 6 independent experiments). f, Western blot confirmed higher CD38 levels in rat cortical astrocytes than in neurons. g, High and low levels of CD38 cyclase activity in astrocytes and neurons, respectively (n = 2 biological replicates, n = 8 or 5 independent experiments). h, Experimental schematic for testing CRISPR/Cas9-mediated CD38 activation. NAD, β-nicotinamide adenine dinucleotide sodium salt (200 μM). i, Twenty-four hours after transfection, CD38 cyclase activity was upregulated by CD38 activation plasmid (n = 2 biological replicates, n = 5 independent experiments). j, k, Extracellular ATP production (j) and oxygen consumption (k) were significantly increased by CD38 activation (n = 2 biological replicates, n = 5 independent experiments). l, FACS showed that extracellular mitochondria were increased by cADPR (1 μ M) stimulation in astrocytes (n = 3 independent experiments). m, cADPR (1 μ M) increased extracellular mitochondria membrane potential at 24 h (n = 2 biological replicates, n = 7 independent experiments). n, Oxygen consumption in extracellular mitochondria was increased by cADPR (n = 2 biological replicates, n = 4 independent experiments). o, cADPR did not cause astrocyte toxicity (n = 2 biological replicates, n = 4 independent experiments). Data are mean ± s.e.m. P values are from an unpaired t-test (c, d, i, j, l, m) or two-way analysis of variance (ANOVA) (e, k, n).
were made dysfunctional via inhibition of mitochondrial aconitase, cADPR-stimulated astrocytes no longer supported neuronal survival and axonal extension (Extended Data Fig. 6 ). To assess our hypothesis further, we asked whether this ability of astrocytes to transfer mitochondria could in fact enhance neuroplasticity under pathological conditions. Control or CD38-silenced astrocytes were co-cultured with surviving neurons after oxygen-glucose deprivation (Fig. 3b ). Short interfering RNA (siRNA) suppression of CD38 in astrocytes reduced mitochondrial transfer ( Fig. 3c ) and dendrite regrowth after injury ( Fig. 3d ). Taken together, these cellular findings appear consistent with the overall hypothesis that CD38 signalling may help astrocytes to transfer mitochondria into neurons and promote survival and plasticity after injury. But it is unclear whether this mechanism works in vivo. To address this question, we turned to a mouse model of focal cerebral ischaemia. First, primary mouse cortical astrocyte cultures were labelled with MitoTracker Red CMXRos and extracellular mitochondrial particles were collected. Mice were then subjected to focal cerebral ischaemia, and 3 days later, extracellular mitochondrial particles were directly injected into the peri-infarct cortex. After 24 h, immunostaining suggested that transplanted astrocytic mitochondria were present in neurons ( Fig. 3e ). Next, we turned to FVB/N-Tg (GFAPGFP)14Mes/J transgenic mice in which astrocytes are fluorescently labelled. When these mice were subjected to focal cerebral ischaemia, fluorescent mitochondrial particle signals appeared within adjacent neurons at 24 h after stroke ( Fig. 3f ). Neurons that were collected from ischaemic peri-infarct cortex via flow cytometry showed a general upregulation of cell-survival-related signals such as phosphorylated AKT and BCL-XL, along with an increase in the mitochondria marker TOM40 (Fig. 3g , Extended Data Fig. 7 ).
Finally, we attempted loss-of-function experiments to determine whether blocking CD38 signalling results in worsened outcomes after stroke. In our mouse model of focal cerebral ischaemia, CD38 was upregulated in the peri-infarct cortex (Extended Data Fig. 8a ). At 5 days after stroke, Cd38 siRNA or control siRNA was injected into cerebral ventricles ( Fig. 4a ). By 2 days after siRNA injections, total CD38 expression in the peri-infarct cortex was successfully downregulated (Extended Data Fig. 8b ). There were no clear differences in infarct area or the total levels of GFAP-positive reactive astrocytes (Fig. 4b, c ), but astrocyte subsets that expressed CD38 were significantly decreased without affecting the number of other CD38-expressing cells such as CD8 T cells and microglia/macrophages 19 (Fig. 4c , Extended Data Fig. 8c -g). To assess the levels of extracellular mitochondrial particles in this in vivo model, flow cytometry was used to analyse cerebrospinal fluid (CSF). GFAP-positive mitochondria were detected in CSF, and Cd38 siRNA injections appeared to reduce this extracellular population of astrocyte-derived mitochondria ( Fig. 4d ). At the same time, flow cytometry was used to quantify levels of MAP2 neuronal mitochondria (Extended Data Fig. 9 ). Brains treated with Cd38 siRNA showed a significant reduction in neuronal mitochondria ( Fig. 4e ), suggesting that interfering with CD38 signalling may have suppressed endogenous astrocyte-to-neuron mitochondrial transfer. These effects were accompanied by a reduction in peri-infarct GAP43 (a surrogate marker of neuroplasticity; Fig. 4f , g) as well as worsened neurological outcomes ( Fig. 4h, i ). Furthermore, CD38 suppression significantly decreased oxygen consumption measurements in CSF-derived extracellular mitochondrial particles (Fig. 4j ), and neurological outcomes seemed to be negatively correlated with these functional endpoints (Fig. 4k, l ), suggesting that CSF mitochondrial function may be a potential biomarker of neuroglial signalling after stroke. Taken together, these findings suggest that astrocytes may release extracellular mitochondrial particles via CD38-mediated mechanisms that enter neurons after stroke (Fig. 4m ). However, there are a few caveats and the detailed mechanisms and generalizability of these proofof-concept findings should warrant further investigation. First, the dynamics of extracellular mitochondria release and entry into neurons as well as quantitative thresholds for functional benefit remain to be fully defined (Extended Data Fig. 10a-i) . A second caveat relates to mitochondrial entry mechanisms. In neurons, endocytosis may be regulated by dynamin/clathrin 20 or integrin pathways 21 . In our models, integrin-mediated Src/Syk signalling may be involved (Extended Data Fig. 10j-m) . How integrin-mediated mitochondrial transfer is modulated under different disease conditions requires further study. Third, CD38 is also expressed in immune cells. In this study, CD38 suppression by siRNA in vivo did not appear to affect T cells or microglia/macrophages, but the balance between potentially beneficial CD38 signals in astrocytes versus deleterious CD38 signals in immune cells should be carefully considered. A fourth caveat is whether other glial cells may participate. Microglia, oligodendrocytes and pericytes are activated after stroke 22, 23 , so their potential roles in mitochondrial exchange warrant further investigation. Finally, astrocytes can produce many factors for protecting and restoring neurons, including tPA, high-mobility group box 1 (HMGB1), extracellular microvesicles containing VEGF and FGF-2, and various microRNAs [24] [25] [26] [27] . How mitochondrial particles may interact with these other extracellular signals should be explored.
Non-cell autonomous signalling is vital for central nervous system recovery after injury or disease 28, 29 . In the context of cerebral ischaemia, the present study suggests that astrocytes may release extracellular mitochondrial particles that enter neurons to support cell viability and recovery after stroke.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Total steps/2 mm Control siRNA (7) Cd38 siRNA (9) j h Control siRNA (7) Cd38 siRNA (9) (9) (7) 
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No statistical methods were used to predetermine sample size. Reagents. BAPTA-AM (A1076), cADPR (C7344), β-nicotinamide adenine dinucleotide sodium salt (N0632) and dynasore hydrate (D7693) were purchased from Sigma, and RGDS peptide (3498) and MNS (2877/50) were from R&D systems. Mouse focal cerebral ischaemia model. All experiments were performed following an institutionally approved protocol in accordance with National Institutes of Health guidelines and with the United States Public Health Service's Policy on Human Care and Use of Laboratory Animals. Our methods also included randomization, blinding and statistical criteria consistent with ARRIVE guidelines (Animals in Research: Reporting In vivo Experiments). In brief, male C57BL/6 J (12-14 weeks) or FVB/N-Tg (GFAPGFP)14Mes/J mice are anaesthetized with 5% to 1% isoflurane, and rectal temperatures and cerebral blood flow are monitored. After midline skin incision, 7-0 nylon monofilament coated with silicon resin was introduced through a small incision into the common carotid artery. Adequate cerebral ischaemia was assessed by Laser Doppler flowmetry and by examining forelimb flexion after the mice recovered from anaesthesia. The mice were reanaesthetized, and reperfusion was established by withdrawal of the filament. Functional outcome after stroke was assessed by neurological severity scores and the foot-fault test 25 . Primary neuron cultures. Primary neuron cultures were prepared from cerebral cortices of embryonic day (E)17 Sprague-Dawley rat embryos or E17 FVB/N-Tg (GFAPGFP)14Mes/J mouse embryos. In brief, cortices were dissected and dissociated using papain dissociation system (Worthington Biochemical Corporation, LK003150). Cells were spread on plates coated with poly-d-lysine (Sigma, P7886) and cultured in DMEM (NBM, Life Technology, 11965-084) containing 25 mM glucose, 4 mM glutamine, 1 mM sodium pyruvate, and 5% FBS at a density of 2 × 10 5 cells ml −1 (1 ml for 12-well format, 0.5 ml for 24-well format). At 24 h after seeding, the medium was changed to Neurobasal medium (Invitrogen, 21103-049) supplemented with B-27 (Invitrogen, 17504044) and 0.5 mM glutamine. Cells were cultured at 37 °C in a humidified chamber of 95% air and 5% CO 2 . Cultures were used for experiments from 7 to 10 days after seeding. Primary astrocyte cultures. Primary astrocyte cultures were prepared from cerebral cortices of 2-day-old neonatal Sprague-Dawley rats or E17 C57BL/6 J mice. In brief, dissociated cortical cells were suspended in DMEM (Life Technology, 11965-084) containing 25 mM glucose, 4 mM glutamine, 1 mM sodium pyruvate, and 10% FBS and plated on uncoated 25 cm 2 flasks at a density of 6 × 10 5 cells cm −2 . Monolayers of type 1 astrocytes were obtained 12-14 days after plating. Nonastrocytic cells such as microglia and neurons were detached from the flasks by shaking and removed by changing the medium. Astrocytes were dissociated by trypsinization and then reseeded on uncoated T75 flasks. After the cells reached 70-80% confluence, cultures were switched to Neurobasal medium containing 1% penicillin/streptomycin or DMEM containing 1% penicillin/streptomycin, and astrocyte-conditioned media (ACM) were collected 24 h later. Collected ACM was treated by spin cell debris down with centrifuging at 2,000g for 10 min or by filtrating through a 1.2-μ m syringe filter for further experiments. OGD and reoxygenation. OGD experiments were performed using a specialized, humidified chamber (Heidolph, incubator 1000, Brinkmann Instruments) kept at 37 °C, which contained an anaerobic gas mixture (90% N 2 , 5% H 2 , and 5% CO 2 ). To initiate OGD, culture medium was replaced with deoxygenated, glucose-free DMEM (Life Technology, 11966-025). After 2 h challenge, cultures were removed from the anaerobic chamber, and the OGD solution in the cultures was replaced with maintenance medium. Cells were then allowed to recover for 18 h (for neurotoxicity assay) and 72 h (for siRNA/astrocyte coculture) in a regular incubator. Cell viability assays. Neuronal injury was measured by standard cell cytotoxicity assays such as lactate dehydrogenase (LDH) using the Cytotoxicity Detection Kit (Roche Applied Science, 11644793001) and/or Cell Counting Kit 8 cytotoxicity assay (DOJINDO, CK04-13). For the LDH assay, 100% cell death was induced with 0.5% Triton X-100 in sister culture. The relative assessments of neuronal injury were normalized by comparison with 100% cell death (LDH assay) or with control cell as 100% cell survival (CCK8). Determination of CD38/ADPR-cyclase activity. ADPR cyclase activity was determined fluorometrically using nicotinamide guanine dinucleotide (NGD + ) (Sigma, N5131) as a substrate as described previously 30, 31 . Astrocytes or neurons were incubated with 200 μ M NGD + , and the production of cGDPR was determined at excitation/emission wavelengths of Ex 300 nm/Em 410 nm with a microplate reader. ATP measurement. Intracellular or extracellular ATP was determined by CellTiter-Glo luminescence kit (Promega, G7570), which can perform cell lysis and generate a luminescent signal proportional to the amount of ATP present. In brief, opaque-walled 96-well plates with culture media (50 μ l) or cell lysate (50 μ l) were prepared. CellTiter-Glo luminescence test solution (50 μ l) was added and incubated for 30 min at room temperature. Luminescent signal was determined by luminescence microplate reader. Liposomal ATP treatment. Liposomal ATP was obtained from Encapsula NanoScience. In brief, we used lyophilized proliposomes compose of 7:3 molar ratio of l-α -phosphatidylcholine: l-α -phosphatidylserine containing ATP which forms 100 nm liposomal ATP upon hydration. ATP-loaded liposome (1-1,000 nM) was co-incubated with neurons following OGD, and cell viability was analysed after 18 h reoxygenation. Mitochondria membrane potential measurement. To monitor mitochondrial health, JC-1 dye (Invitrogen, T-3168) was used to assess mitochondrial membrane potential. Rat cortical astrocytes or media were incubated with JC1 (5 μ M or 1 μ M) for 30 min at 37 °C. JC1 dye exhibits potential-dependent accumulation in mitochondria, indicated by fluorescence emission shift from green (Ex 485 nm/Em 516 nm) to red (Ex 579 nm/Em 599 nm). Mitochondria membrane potential was determined by the fluorescent ratio with a fluorescent microplate reader. Oxygen consumption analysis. Real-time oxygen consumption in astrocytic particles or in CSF samples was measured by the Mito-ID Extracellular O2 sensor kit (Enzo Life Science, ENZ-51045) according to the instruction provided Enzo Life Science. In brief, astrocytes (70-80% confluent cells per well per 100 μ l) or particle fractions (100 μ l; 25-fold concentrated astrocytic conditioned media) were prepared in non-coated regular 96 wells, and O 2 sensor probe (10 μ l) was added into each well. Each CSF sample (8-20 μ l) was collected from cisterna magna at day 7 after focal cerebral ischaemia. After centrifugation at 2,000g for 10 min, 6 μ l CSF was diluted in 54 μ l PBS, and 6 μ l O 2 sensor probe was added into each well. After covering with 100 μ l (50 μ l for CSF sample) of Mito-ID HS Oil, the plates were read with filter combination of 340 nm for excitation and 642 nm of emission at 30 °C. Electron microscopy analysis. Rat cortical astrocytes or pellets from astrocyteconditioned media were fixed in 2.0% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4 (Electron Microscopy Sciences) for 1 h at room temperature on a rocker. They were rinsed in cacodylate buffer, gently scraped and pelleted and post-fixed in 1.0% osmium tetroxide in cacodylate buffer for 1 h on ice. They were rinsed in buffer and stabilized with a small amount of 2% agarose in PBS to hold them together. They were then dehydrated through a graded series of ethanol to 100%, followed by propylene oxide, 100%. They were infiltrated with Epon resin (Ted Pella) in a 1:1 solution of Epon:propylene oxide overnight on a rocker at room temperature. The next day they were placed in fresh Epon for several hours and then embedded in Epon overnight at 60 °C. Thin sections were cut on a Leica EM UC7 ultramicrotome, collected on formvar-coated grids, stained with uranyl acetate and lead citrate and examined in a JEOL JEM 1011 transmission electron microscope at 80 kV. Images were collected using an AMT digital imaging system (Advanced Microscopy Techniques). These methods are similar to previous descriptions of extracellular particle and mitochondria detection in astrocyte cultures 12 . FACS analysis. Standard FACS analysis was performed by BD LSR II or BD Fortessa as described previously 25, 32, 33 . ACM was collected from rat cortical astrocytes labelled with MitoTracker Red CMXRos followed by filtrating through a 1.2-μ m syringe filter. The supernatant was used to sort labelled mitochondria fraction by FACSAriaII cell sorter configured with 561 nm air cooled laser. Brain cells were collected from peri-infarct cortex after stroke. In brief, tissues are gently minced and then digested at 37 °C for 30 min with an enzyme cocktail (collagenase type I, DNase I, Sigma Aldrich). CSF samples were prepared for further staining after centrifugation at 2,000g for 10 min. FACS analysis was performed using an unstained or phenotype control for determining appropriate gates, voltages, and compensations required in multivariate flow cytometry. Measurement of particle size. Particle size following extracellular mitochondria isolation by FACS was determined by qNano (iZON). Nanopore-based detection allows particle-by-particle assessment of complex mixtures. Optimization of pore size to particle size, by adjusting the stretch of the pore, allows highly accurate measurement 34 . Particles containing mitochondria were sorted using FACS analysis, then particle sizes were quantified by NP400 and using CPC400 calibration particle. Western blot analysis. Western blot was performed as previously reported 25 . Pro-PREP Protein Extraction Solution (iNtRON Biotechnology, 17081) or Qproteome FFPE Tissue kit (Qiagen, 37623) was used to collect samples. Each sample was loaded onto 4-20% Tris-glycine gels. After electrophoresis and transferring to nitrocellulose membranes, the membranes were blocked in Tris-buffered saline containing 0.1% Tween 20 and 0.2% I-block (Tropix, T2015) for 90 min at room temperature. Membranes were then incubated overnight at 4 °C with the following primary antibodies, anti-β -actin (1:1,000, Sigma-Aldrich, A5441), anti-GFAP antibody (1:1,000, BD Biosciences, 556328), anti-MAP2 antibody (1:500, Abcam, ab11267 or ab32454), anti-CD38 antibody (1:500, Santacruz, sc-7049), anti-TOM40 (1:200, Santacruz, sc-11414), anti-phosphorylated AKT (1:500, Cell Signaling, 9271), anti-BCL-XL (1:500, Cell Signaling, 2764), anti-active caspase 3
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(1:200, Abcam, ab32042), anti-AIF (1:500, Abcam, ab32516), and anti-GAP43 (1:500, Santacruz, sc-17790). After incubation with peroxidase-conjugated secondary antibodies, visualization was enhanced by chemiluminescence (GE Healthcare, NA931 (anti-mouse), NA934 (anti-rabbit), or NA935 (anti-rat)). Optical density was assessed using the NIH Image analysis software. Immunocytochemistry and immunohistochemistry. Immunocytochemistry and immunohistochemistry were performed as described previously 35, 36 . After staining with primary antibody and fluorescent-tagged secondary antibody, nuclei were counterstained with or without 4,6-diamidino-2-phenylindole (DAPI), and coverslips were placed. Immunostaining images or time lapse images were obtained with a fluorescence microscope (Nikon ECLIPSE Ti-S) interfaced with a digital charge-coupled device camera and an image analysis system or confocal microscope analysis using Carl Zeiss Laser Scanning Confocal Microscope Pascal 5 LSM and Pascal 5 LSM software Version 3.2. Dendrite elongation was assessed following MAP2 staining followed by NeuriteQuant analysis 37 . CRISPR activation plasmid transfection. Control CRISPR activation plasmid (sc-437275), and rat CD38 CRISPR activation plasmid (sc-437321-ACT) were obtained from Santa Cruz Biotechnology. Transfection was performed according to the transfection protocol for cell cultures from Santa Cruz Biotechnology. In brief, 1 ml of plasmid transfection reagent mixture (transfection reagent, sc-395739, transfection medium, sc-108062) was co-incubated with astrocytes for 24 h in a 5% CO 2 incubator at 37 °C, and then CD38 cyclase activity was assessed to confirm efficiency of transfection. siRNA experiments. Control siRNA and Cd38 siRNA were obtained from Santa Cruz Biotechnology. Control siRNA (sc-37007) consists of a scrambled sequence that will not lead to the specific degradation of any known cellular mRNA. Mouse Cd38 siRNA (sc-37246) or rat Cd38 siRNA (sc-270394) is each pool of 3 targetspecific 19-25-nucleotide siRNAs designed to knock down gene expression. The sequences for mouse Cd38 siRNAs are: 5′ -GUGUACUACCAACAUUCAA-3′ , 5′ -GUGUGUCUUUAGUAGGUAU-3′ , 5′ -CCAGUUUGUGAUUGUUGA-3′ . Rat Cd38 siRNAs are: sequence 1: 5′ -CUCAAACCAUACCAUGUAA-3′ , sequence 2: 5′ -GGAAGAGCUUCCCAAUACA-3′ , sequence 3: 5′ -GUGUUAU CGUCUAGCAAUA-3′ . siRNA was prepared according to the transfection protocol for cell cultures from Santa Cruz Biotechnology. In brief, 1 ml of siRNA transfection reagent mixture (transfection reagent, sc-29528, transfection medium, sc-36868) was co-incubated with astrocytes for 6 h in a 5% CO 2 incubator at 37 °C, and then the same amount of DMEM 20% FBS was added. An additional incubation was performed for 18 h. Statistical analysis. Results were expressed as mean ± s.e.m. When only two groups were compared, an unpaired t-test was used. Multiple comparisons were evaluated by one-way ANOVA followed by Tukey's test, two-way ANOVA or repeated-measure two-way ANOVA followed by Bonferroni test. Correlation was evaluated by Spearman's rank correlation. P < 0.05 was considered statistically significant. Statistical analyses were performed using GraphPad Prism 6.
Extended Data Figure 5 | Role of astrocytic CD38 in mitochondria transfer during starvation in vitro. a, Immunocytochemistry in neuron-astrocyte co-cultures demonstrated that CD38 was primarily expressed within astrocytes. b, Extracellular ATP levels were higher in media collected from neurons co-cultured with astrocytes compared to media from neuron-alone cultures (n = 3 biological replicates, n = 9 or 11 independent experiments). c, After serum/glucose starvation, neurons were significantly damaged, as expected. But neurons co-cultured with astrocytes were protected (n = 2 biological replicates, n = 6 or 4 independent experiments). d, CD38 suppression by siRNA significantly decreased extracellular ATP levels in neuron-astrocyte co-cultures, but CD38 suppression did not affect extracellular ATP levels in neuron-alone cultures (n = 3 biological replicates, n = 9 or 6 independent experiments). e, Blockade of astrocytic CD38 by siRNA significantly increased LDH release (indicative of cell damage) in the co-cultures, suggesting that CD38 may be important for maintaining neuroglial homeostasis (n = 2 biological replicates, n = 6 independent experiments). f, Rat primary neurons were co-cultured with rat astrocytes. Immunocytochemistry showed that CD38 suppression by siRNA reduced astrocytic mitochondria (red) transfer into neurons compared to control. g, h, Western blot analysis indicated that CD38 suppression by siRNA can be successfully performed in astrocyte culture without affecting cell viability (n = 2 biological replicates, n = 4 or 3 independent experiments). Data are mean ± s.e.m. P values are from an unpaired t-test.
